| abstract |
In particular, the present disclosure relates to RNA molecules (eg, RNA hairpin agonists) that bind to and agonize RIG-I-like receptors (RLRs), and such molecules, including RLR agonists packaged in virus-like particles (VLPs), Use in a method for treating a disorder (eg, cancer) or ameliorating one or more symptoms of the disorder. |